Obesity Clinical Trial
— PRONAFOfficial title:
Nutrition and Physical Activity Programs for Obesity Treatment (PRONAF)
| NCT number | NCT01116856 |
| Other study ID # | PRONAF |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 2009 |
| Est. completion date | December 2011 |
| Verified date | October 2019 |
| Source | Universidad Politecnica de Madrid |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
At the present time, scientific consensus exists on obesity multifactorial etiopatogenia. As
well, professionals and researchers agree that the treatment must approach several scopes,
such as dietetic, physical activity, pharmacologic and surgical. These two last ones should
not be the first election and must be reserved for those cases of morbid obesities or in case
the previous ones have failed. The combination of diet and exercise is still not sufficiently
studied, in special, the addition of strength training, as we propose in this project, for
which established intervention protocols do not exist, and that could suppose an additional
benefit in the reduction of risk factors.
Therefore, the objectives that we aim in this project are enumerated below:
- To discover which are the most effective training protocols and to determine what type
of exercise combined with nutrition is more appropriate for obesity intervention
programs.
- To establish the relationship between markers related with cardiovascular risk
(adopokines and lipid profile) and the different intervention protocols proposed.
- To describe the influence of nine genetic polymorphisms (selected by their relationship
with the energy expense and the physical yield) on the effect of different training
protocols.
- To determine how important is body composition (fat mass and muscle mass mainly) in
total daily energy expenditure.
- To establish rules of nutritional and exercise intervention that can be applied in
public and private training centers. If the proposed objectives are fulfilled, this
would contribute to an improvement in patients health in long term, along with an
enormous saving in public health. Therefore, the purpose of this project is to propose
new lines of intervention in overweight and obese adults that, until now, little have
been investigated. This way, resistance training is proposed in combination with
cardiovascular training and endocrinologic treatment. It fits to emphasize that, as far
as we know, it is the first project of these characteristics, that puts in touch the
public and private sector (hospitals, universities and fitness area), to establish
standardized relations protocols to allow a close pursuit of obese patients.
| Status | Completed |
| Enrollment | 240 |
| Est. completion date | December 2011 |
| Est. primary completion date | January 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 50 Years |
| Eligibility |
For Overweight phase: Inclusion Criteria: - Volunteers: men and women from Comunidad de Madrid (Zone 5 of Health System) who sign the informed consent. - Ages 18 - 50 years old. - Pre-menopausal. - Body mass index (BMI) of 25 - 30 kg•m-2 (both included). - Able to attend exercise classes 3 times per week (Monday, Wednesday and Friday). No plans for excessive travel. No plans to move from area for study period (January 2010 - June 2010, both included). - Able to follow the nutritional treatment (avoid medication or substances known to interfere with body weight regulation, including anti-depressive medication, diuretics, etc., 15 days before study starts). - Willing to not participate in other formal or informal weight loss program during the period of the study. - Sedentary (less than once a week of training or two hours of physical activity class). Exclusion Criteria: - Smoking within six months, or use of tobacco or nicotine product. - Women with irregular menstrual cycle (except with hormone therapy). - Following a weight loss diet, vegetarians or food restriction due to religion. - Self-reported weight loss or gain >5% in past 6 months. - Are not pregnant, or haven´t been in the past six months. Are not currently nursing or planning to become pregnant during the study period (year 2010). - Need a special diet by associated disease (celiac disease or chronic renal insufficiency). - Have metabolic syndrome or fulfill three or more of the following criteria: abdominal obesity (waist diameter > 102 cm in men and > 88 cm in women), blood pressure = 130/85 mm Hg, basal glycemia = 110 mg/dL, triglyceride level > 150 mg/dL and C-HDL < 40 mg/dL in women and < 50 mg/dL in men. - Diabetes. - Anemia (Hct < 37%). - Uncontrolled high blood pressure (Systolic > 160 mm Hg or diastolic > 100 mm Hg in rest). Current use of more than one anti-hypertensive medication. - Substance abuse (drugs, alcohol…). High or moderate consumes of alcohol. More than 2 glasses to the day of any alcoholic substance. Current use of diuretics, beta blockers, steroids or blood thinners. - Contraindication to exercise. Alterations, syndromes or diseases detected by electrocardiogram (EKG) o echocardiography. Have injuries o pathologies of the locomotive apparatus that prevent the correct execution of the exercises of the program. Any illness that would prevent participation in a moderate-intense exercise program. - Have had cancer in the past 5 years, except skin cancer. - Coronary artery disease, liver disease, pulmonary disease, renal disease or other systemic disorders. - History or evidence of cardiovascular disease, alterations, syndromes or other mayor chronic illness. Have history of heart disease, heart attacks or heart surgery. - Have any illness known to interfere with body weight loss: clinical depression, eating disorder (anorexia, bulimia, etc.), psychological diseases (schizophrenia, etc.), dementia or cognitive function decreased, hypothyroidism no controlled or history of genetic or chromosomal disorder. - Have had bariatric surgery or stomach bypass surgery. - Gross physical impairment. - Blindness or retinopathy. For Obese phase: Inclusion Criteria: - Volunteers: men and women from Comunidad de Madrid (Zone 5 of Health System) who sign the informed consent. - Ages 18 - 50 years old. - Pre-menopausal. - Body mass index (BMI) of 30 - 35 kg•m-2 (both included). - Able to attend exercise classes 3 times per week (Monday, Wednesday and Friday). No plans for excessive travel. No plans to move from area for study period (January 2011 - June 2011, both included). - Able to follow the nutritional treatment (avoid medication or substances known to interfere with body weight regulation, including anti-depressive medication, diuretics, etc., 15 days before study starts). - Willing to not participate in other formal or informal weight loss program during the period of the study. - Sedentary (less than once a week of training or two hours of physical activity class). Exclusion Criteria: - Smoking within six months, or use of tobacco or nicotine product. - Women with irregular menstrual cycle (except with hormone therapy). - Following a weight loss diet, vegetarians or food restriction due to religion. - Self-reported weight loss or gain >5% in past 6 months. - Are not pregnant, or haven´t been in the past six months. Are not currently nursing or planning to become pregnant during the study period (year 2011). - Need a special diet by associated disease (celiac disease or chronic renal insufficiency). - Have metabolic syndrome or fulfill three or more of the following criteria: abdominal obesity (waist diameter > 102 cm in men and > 88 cm in women), blood pressure = 130/85 mm Hg, basal glycemia = 110 mg/dL, triglyceride level > 150 mg/dL and C-HDL < 40 mg/dL in women and < 50 mg/dL in men. - Diabetes. - Anemia (Hct < 37%). - Uncontrolled high blood pressure (Systolic > 160 mm Hg or diastolic > 100 mm Hg in rest). Current use of more than one anti-hypertensive medication. - Substance abuse (drugs, alcohol…). High or moderate consumes of alcohol. More than 2 glasses to the day of any alcoholic substance. Current use of diuretics, beta blockers, steroids or blood thinners. - Contraindication to exercise. Alterations, syndromes or diseases detected by electrocardiogram (EKG) o echocardiography. Have injuries o pathologies of the locomotive apparatus that prevent the correct execution of the exercises of the program. Any illness that would prevent participation in a moderate-intense exercise program. - Have had cancer in the past 5 years, except skin cancer. - Coronary artery disease, liver disease, pulmonary disease, renal disease or other systemic disorders. - History or evidence of cardiovascular disease, alterations, syndromes or other mayor chronic illness. Have history of heart disease, heart attacks or heart surgery. - Have any illness known to interfere with body weight loss: clinical depression, eating disorder (anorexia, bulimia, etc.), psychological diseases (schizophrenia, etc.), dementia or cognitive function decreased, hypothyroidism no controlled or history of genetic or chromosomal disorder. - Have had bariatric surgery or stomach bypass surgery. - Gross physical impairment. - Blindness or retinopathy. |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Facultad de Ciencias de la Actividad Física y del Deporte | Madrid | |
| Spain | Pedro J. Benito Peinado | Madrid |
| Lead Sponsor | Collaborator |
|---|---|
| Universidad Politecnica de Madrid | Hospital Universitario La Paz, Hospital Universitario Marqués de Valdecilla, Universidad Complutense de Madrid |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Body composition | After 16 weeks of intervention | ||
| Primary | Health status | After 16 weeks of intervention | ||
| Primary | Cardiorespiratory fitness | After 16 weeks of intervention | ||
| Secondary | Quality of life | After 16 weeks of intervention |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |